Breast Cancer Triple-N

Breast cancer cells have receptors for estrogen, progesterone, HER2 receptors (also called ERBB2). Triple-negative breast cancers do not have any of these receptors. Here are the latest discoveries pertaining to triple-negative breast cancers.

April 18, 2021

NSDHL promotes triple-negative breast cancer metastasis through the TGFβ signaling pathway and cholesterol biosynthesis.

Breast Cancer Research and Treatment
Mengting ChenWei Jin
April 18, 2021

Radioguided surgery with iodine-125 seeds in breast cancer patients treated with neoadjuvant chemotherapy.

Revista española de medicina nuclear e imagen molecular
A C Rebollo AguirreS Martínez Meca
April 17, 2021

Poly (ADP-ribose) polymerase inhibitors in solid tumours: Systematic review and meta-analysis.

European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
Francesco SchettiniDaniele Generali
April 16, 2021
Open Access

Second-line Eribulin in Triple Negative Metastatic Breast Cancer patients. Multicentre Retrospective Study: The TETRIS Trial.

International Journal of Medical Sciences
Eriseld KrasniqiPatrizia Vici
April 16, 2021
Open Access

Obesity-related proteins score as a potential marker of breast cancer risk.

Scientific Reports
Sha DiaoJiayuan Li
April 16, 2021

Actin cytoskeletal structure and the statistical variations of the mechanical properties of non-tumorigenic breast and triple-negative breast cancer cells.

Journal of the Mechanical Behavior of Biomedical Materials
Killian OnwudiweWinston Soboyejo
April 16, 2021

Exploring the Potential of Metallodrugs as Chemotherapeutics for Triple Negative Breast Cancer.

Chemistry : a European Journal
Maria Contel, Nazia Nayeem
April 16, 2021

Impact of emerging clinical trends on overall cost of care and the role of the managed care pharmacist.

The American Journal of Managed Care
Rebecca Tombleson
April 16, 2021

Current treatment landscape and emerging therapies for metastatic triple-negative breast cancer.

The American Journal of Managed Care
Nelly G Adel
April 16, 2021
Open Access

Alteration of DNA Damage Response Causes Cleft Palate.

Frontiers in Physiology
Hiroyuki YamaguchiYoshihiro Komatsu
April 16, 2021
Open Access

Repositioning metformin and propranolol for colorectal and triple negative breast cancers treatment.

Scientific Reports
L E AnselminoM Menacho Márquez
April 16, 2021

Defining super-enhancer landscape in triple-negative breast cancer by multiomic profiling.

Nature Communications
Hao HuangY Rebecca Chin
April 15, 2021

PARP Inhibitor in Platinum-Resistant Ovarian Cancer: Single-Center Real-World Experience.

JCO Global Oncology
Amit AgarwalGuresh Kumar

Sign up to follow this feed and discover related papers.

Related Feeds

Breast Cancer: BRCA1 & BRCA2

Mutations involving BRCA1, found on chromosome 17, and BRCA2, found on chromosome 13, increase the risk for specific cancers, such as breast cancer. Discover the last research on breast cancer BRCA1 and BRCA2 here.

Breast Cancer: Chemo-Resistance

Some cancers are difficult to treat and aggressive including the "triple-negative" breast cancer. This type of cancer is chemoresistant even before chemotherapy begins. Here are the latest discoveries chemo-resistance in breast cancer.

Breast Cancer: Risk Factors

Breast cancer is a multifactorial disease that is influenced by both environmental and genetic factors. Discover the latest research on the environmental and genetic risk factors for breast cancer here.

Breast Cancer: Therapeutic Approaches

Several different therapeutic approaches are used to treat breast cancer. These include chemotherapy, hormonal therapy, targeted therapy, and Immunotherapy. Discover the latest research on breast cancer therapeutic approaches here.

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Breast Tumorigenesis

Breast tumorigenesis involves the production or formation of tumor(s) in breast tissue. Discover the latest research on breast tumorigenesis here.

Carcinoma, Lobular

Lobular carcinoma is an invasive type of breast cancer in which lobules, areas of the breast that produce milk, undergo malignant transformation. Here is the latest research.

Hereditary Breast & Ovarian Cancer

Hereditary breast and ovarian cancer due to mutations in the brca1 and brca2 genes is the most common cause of hereditary forms of both breast and ovarian cancer. Here are the latest discoveries pertaining to these cancers.

Inflammatory Breast Neoplasms

Inflammatory breast cancer is a rare disease characterized by edema and redness of the breast. This is caused by metastatic breast cancer cells blocking lymphatic vessels. Discover the latest research on Inflammatory breast cancer here.

© 2021 Meta ULC. All rights reserved